Reputation and power: Organizational image and pharmaceutical regulation at the FDA

D Carpenter - Reputation and Power, 2014 - degruyter.com
… conceived, Reputation and Power demonstrates how much our modern system of drug
regulation and clinical research owes to the scientific creativity and political skills of federal drug

Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. By Daniel Carpenter. Princeton: Princeton University Press, 2010. 856p …

J Ferejohn - Perspectives on Politics, 2012 - cambridge.org
Dan Carpenter's massive new study of the Food and Drug Administration (FDA) is a definitive
study of regulatory politics and administrative behavior destined to stand alongside other …

Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA

N Rasmussen - Bulletin of the History of Medicine, 2011 - muse.jhu.edu
regulation in the United States upon the historical foundation … drug regulation by the Food
and Drug Administration (FDA). The United States is not under-regulated, he argues: the FDA

… : Organizational Image and Pharmaceutical Regulation at the FDA by Daniel Carpenter” Reputation and Power: Organizational Image and Pharmaceutical Regulation …

GJ Miller - 2010 - Taylor & Francis
… and strength, the weakening of the FDA should offer special opportunities to develop and …
of the growth of FDA's power and authority, then what of expertise, reputation, and power in the …

Reputation and power. Organizational image and pharmaceutical regulation at the FDA

N Gally - 2011 - JSTOR
… en raison de la persistance des images, symboles, croyances et postulats sur lesquels
repose la régulation pharmaceutique, étroitement liés à l'histoire de la FDA et à la construction …

Daniel Carpenter, Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA

L Richert - 2011 - academic.oup.com
… of drug regulation and avoid an oversimplification of FDA … the FDA is neither a puppet of the
unscrupulous drug industry… deprive Americans of lifesaving drugs. Despite recent criticism for …

Reputation and Power. Organizational Image and Pharmaceutical Regulation at the FDA. by Daniel Carpenter. Princeton and Oxford: Princeton University Press, 2010 …

A Spina - European Journal of Risk Regulation, 2012 - cambridge.org
… communication strategies of regulatory organizations. Daniel … the FDA’s reputational power
makes Reputation and Power … the real dynamics of power within regimes of risk regulation. …

Response to John Ferejohn's review of Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA

D Carpenter - Perspectives on Politics, 2012 - cambridge.org
… knowledge about drugs before their marketing, one would also opt for many elements of
the current system. If there is a form of capture at work in modern pharmaceutical regulation, I …

Daniel Carpenter/Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (Princeton, NJ/Oxford, UK: Princeton University Press …

A Muzur - Jahr–European Journal of Bioethics, 2010 - hrcak.srce.hr
… , that exception has occured: there is no better manner to describe the role, destiny, and
reality of the US Food and Drug Administration, but by the two key words: reputation and power. …

Reputation, information and confidence: The political economy of pharmaceutical regulation

D Carpenter - Research Handbook on Public Choice and Public …, 2010 - elgaronline.com
… and Drug Administration (FDA), a storied organization that exercises significant administrative
… and has deeply shaped the laws and regulations by which it has been given regulatory